MD PhD | Research Fellow | @AnatNeu_Ams @MScentrum020 @AmsterdamUMC
Joined November 2011
- Tweets75
- Following62
- Followers59
- Likes67
Tom Fuchs retweeted
⬛️Predictive tools shouldn’t be black boxes.
Dr. Fuchs (@FuchsTom, @amsterdamumc), discusses the clinician‑friendly ML models his team & @MSBase_Registry partners built to provide individualized 5-year progression risk estimates in #MS➡️ buff.ly/R5mLoK9
#NeuroTwitter
Grateful for the opportunity to speak with Lisa A. Tomaszewski at Physicians Weekly about our recent work using machine learning to predict disease progression in multiple sclerosis.
One idea that came through strongly in our conversation: better algorithms alone are not enough. If predictive tools are going to improve patient care, they must also be transparent, interpretable, globally validated, and designed with the realities of clinical practice in mind.
I’m excited to be working at the intersection of neuroscience, clinical medicine, and machine learning as these technologies begin shaping the future of patient care.
See the interview here!
physiciansweekly.com/post/qa… – at Amsterdam, The Netherlands
Tom Fuchs retweeted
🧠📊 New on NeurologyLive®: @FuchsTom, of @amsterdamumc, explores machine learning models designed to predict disease progression in multiple sclerosis using clinically accessible data—focused on usability and clinical decision support.
🔗 Read more 👉 hubs.li/Q04f1lJx0
Just published! An excellent article by the brilliant Daan de Jong. Dr. de Jong explores practice effects with repeat cognitive assessment and whether this in itself can be used to understand the status of people with multiple sclerosis.
link.springer.com/article/10…
Disease progression in multiple sclerosis can be reliably predicted using clinically accessible information and technology.
See our latest publication in Journal of Neurology about the development and validation of the new DAAE-M and ELIE scores!
The manuscript: link.springer.com/article/10…
The online tools: tomafuchs.com/public-tools/
Thank you to @ECTRIMS, @MScentrum020, @MSBase_Registry, for supporting this work - and to my mentors and collaborators @Mennoke, Eva Strijbis, @JelgerhuisJ, @BiancaGuttman, and Robert Zivadinov
When considering spinal cord atrophy as a measure of pathology, it is important to also account for natural variability. See this excellent publication by Daan de Jong
bit.ly/4tKJpCv
Cognitive decline can worsen independent of relapse in multiple sclerosis and is best predicted by early neurodegeneration. An important new article by Stefano Ziccardi & Massimiliano Calabrese
bit.ly/4c4YrMY
I had an excellent discussion with Victoria Leavitt and Brett Drummond during this session at @ECTRIMS conference! Looking forward to future advancements worth debating : ) – at Amsterdam, The Netherlands
🎙️ “Cognition is a window into otherwise uncaptured disease progression, and that is a reason to measure it. That then allows us to then decide if what we are doing for our patients is right.” Tom Fuchs from @AmsNeuroscience in the latest ECTRIMS Podcast on cognition
🎧 Listen now: bit.ly/48vMjm7
#ECTRIMSPodcast #MultipleSclerosis #Cognition #MSResearch #Neurology #MSCommunity @MStranslate
Tom Fuchs retweeted
Cognitive symptoms in MS are common—but not always captured well by current tools. In our latest podcast, Vicky Leavitt from @Columbia and Tom Fuchs from @AmsNeuroscience talk about the state of cognition research, if measurement still lags behind clinical need, and how new tools may change the field forever.
🎧 Listen now:
Apple: apple.co/4oMh8HY
#ECTRIMSPodcast #MultipleSclerosis #Cognition #MSResearch #Neurology #MSCommunity @MStranslate
Tom Fuchs retweeted
🎙️ “Cognition is a window into otherwise uncaptured disease progression, and that is a reason to measure it. That then allows us to then decide if what we are doing for our patients is right.” Tom Fuchs from @AmsNeuroscience in the latest ECTRIMS Podcast on cognition
🎧 Listen now: bit.ly/48vMjm7
#ECTRIMSPodcast #MultipleSclerosis #Cognition #MSResearch #Neurology #MSCommunity @MStranslate
Thank you @ECTRIMS for supporting this work, to the committee for honoring us with this award, and to my incredible mentors and collaborators! I am proud of this research, unraveling the functional brain underpinnings of disease progression in people with multiple sclerosis. – at el Prat de Llobregat, Espanya
Tom Fuchs retweeted
By testing the SDMT monthly across 3 years, the plateau of practice effects was reached after 18 repetitions, suggesting that alternate versions and reliable-change methodologies should be considered.
Study from @goteborgsuni @sahlgrenska ▶️ journals.sagepub.com/doi/ful…
Disease progression in MS is predictable using clinically accessible information and technology. Congratulations to the brilliant Julia Jelgerhuis for this excellent work! And thank you to our wonderful partners in Prague who have been extraordinary scientific collaborators.
The manuscript: bit.ly/daae_p
The tool: bit.ly/466yozW
@JelgerhuisJ @AnatNeu_Ams @MScentrum020 @AmsterdamUMC
How does cognitive testing contribute to personalized care for patients with multiple sclerosis? See my recent article in @neurology_live addressing this question
bit.ly/cogforpersonalized
This work supported by @ECTRIMS @AnatNeu_Ams
@MScentrum020